Clinical Trial Update: Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial ANRS 147 OPTIPRIM evaluating optimization of treatment for primary HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infections | Phase 3 | Status: COMPLETED